ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,855
Screening encounters
4,541
Diagnostic referrals
866
Outstanding pathways
311

Screening pathway

  1. Screening4,541Encounters
  2. Positive finding1,570Documented findings
  3. Referral866Diagnostic referrals
  4. Follow-up1,030Diagnostic visits
  5. Outcome555Resolved pathways

Stage totals use different units. Pending pathways: 311. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2256 · EXP-2256Synthetic · Site A

Full participant history through 2026-11-22, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA negative
  4. · Surveillance plan · HPV DNA · HPV positive with negative triage · Scheduled for 2028-07-08

Referral-time risk

No matching referral was available at this observation date.

Screened participants

3855 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3028 · Expanded synthetic participant 3028Site E — Resource-Constrained Navigation Programme
EXP-3029 · Expanded synthetic participant 3029Site D — Community Engagement Programme
EXP-3030 · Expanded synthetic participant 3030Site C — Rural Outreach Programme
EXP-3031 · Expanded synthetic participant 3031Site A — Urban Referral Hub
EXP-3032 · Expanded synthetic participant 3032Site C — Rural Outreach Programme
EXP-3033 · Expanded synthetic participant 3033Site C — Rural Outreach Programme
EXP-3034 · Expanded synthetic participant 3034Site A — Urban Referral Hub
EXP-3035 · Expanded synthetic participant 3035Site A — Urban Referral Hub
EXP-3036 · Expanded synthetic participant 3036Site E — Resource-Constrained Navigation Programme
EXP-3038 · Expanded synthetic participant 3038Site C — Rural Outreach Programme
EXP-3040 · Expanded synthetic participant 3040Site E — Resource-Constrained Navigation Programme
EXP-3041 · Expanded synthetic participant 3041Site B — Peri-Urban Access Programme
EXP-3042 · Expanded synthetic participant 3042Site B — Peri-Urban Access Programme
EXP-3043 · Expanded synthetic participant 3043Site D — Community Engagement Programme
EXP-3044 · Expanded synthetic participant 3044Site D — Community Engagement Programme
EXP-3045 · Expanded synthetic participant 3045Site D — Community Engagement Programme
EXP-3046 · Expanded synthetic participant 3046Site E — Resource-Constrained Navigation Programme
EXP-3047 · Expanded synthetic participant 3047Site B — Peri-Urban Access Programme
EXP-3049 · Expanded synthetic participant 3049Site D — Community Engagement Programme
EXP-3052 · Expanded synthetic participant 3052Site E — Resource-Constrained Navigation Programme
EXP-3053 · Expanded synthetic participant 3053Site D — Community Engagement Programme
EXP-3054 · Expanded synthetic participant 3054Site C — Rural Outreach Programme
EXP-3055 · Expanded synthetic participant 3055Site C — Rural Outreach Programme
EXP-3056 · Expanded synthetic participant 3056Site D — Community Engagement Programme
EXP-3057 · Expanded synthetic participant 3057Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1736
HPV DNA
2166
Cytology
639

Navigation activity

Barrier documented
768
Contact attempt
1272
Navigation intervention
333
Diagnostic booking
1081
Diagnostic visit
1030

Documented barriers

Contact difficulty
247
Transport difficulty
253
Appointment coordination
268

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.